Applied Materials (AMAT) Stock Week Ahead: Holiday-Shortened Trading, AI Equipment Demand Signals, and China Export-Curb Crosswinds (Dec 22–26, 2025)

Applied Materials (AMAT) Stock Week Ahead: Holiday-Shortened Trading, AI Equipment Demand Signals, and China Export-Curb Crosswinds (Dec 22–26, 2025)

Dec. 21, 2025 — Applied Materials, Inc. (NASDAQ: AMAT) heads into a holiday-shortened trading week with its stock near recent highs, investors focused on two big, competing forces: AI-driven wafer-fab equipment demand and ongoing U.S.-China export-control uncertainty. AMAT last traded
Costco Stock (COST) Week Ahead: Fresh News, Analyst Forecasts, and Key Levels to Watch Into Christmas Week

Costco Stock (COST) Week Ahead: Fresh News, Analyst Forecasts, and Key Levels to Watch Into Christmas Week

Costco Wholesale Corporation (NASDAQ: COST) heads into the week of December 22–26, 2025 with investors juggling two competing narratives: a fundamentally strong, membership-driven retailer that just posted solid quarterly results—versus a stock that has slid meaningfully from its early-2025 highs
Alphabet (GOOG) Class C Stock Week Ahead: Google Cloud’s $10B Security Deal, Waymo Funding Buzz, and Antitrust Risk in Focus (Dec. 22–26, 2025)

Alphabet (GOOG) Class C Stock Week Ahead: Google Cloud’s $10B Security Deal, Waymo Funding Buzz, and Antitrust Risk in Focus (Dec. 22–26, 2025)

Alphabet Inc.’s Class C shares (NASDAQ: GOOG) head into the Christmas week with investors balancing a familiar 2025 tug-of-war: AI-driven growth and “mega-cap momentum” on one side, and regulatory/antitrust uncertainty plus heavy AI infrastructure spending on the other. GOOG last
Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) has effectively shifted from a “biotech story stock” to a deal-driven stock. The reason is simple and decisive: BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to acquire Amicus in an all-cash
Oracle Stock (ORCL) Week Ahead: TikTok Joint Venture Headlines, OpenAI “Stargate” Spending Fears, and Key Levels to Watch (Dec. 22–26, 2025)

Oracle Stock (ORCL) Week Ahead: TikTok Joint Venture Headlines, OpenAI “Stargate” Spending Fears, and Key Levels to Watch (Dec. 22–26, 2025)

Published: December 21, 2025 Oracle Corporation (NYSE: ORCL) heads into a holiday-shortened Christmas trading week with two powerful forces pulling the stock in opposite directions: a fresh catalyst from the newly signed TikTok U.S. joint venture agreement, and ongoing investor
Go toTop